0001209191-13-037017.txt : 20130717 0001209191-13-037017.hdr.sgml : 20130717 20130717163924 ACCESSION NUMBER: 0001209191-13-037017 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130715 FILED AS OF DATE: 20130717 DATE AS OF CHANGE: 20130717 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6173416100 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Silva Paul M CENTRAL INDEX KEY: 0001446372 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 13972935 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2013-07-15 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001446372 Silva Paul M C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST. CAMBRIDGE MA 02139 0 1 0 0 SVP & Corp Controller Common Stock 2013-07-15 4 M 0 469 33.82 A 12219 D Common Stock 2013-07-15 4 M 0 1125 51.75 A 13344 D Common Stock 2013-07-15 4 S 0 1494 86.34 D 11850 D Common Stock 2013-07-15 4 S 0 100 87.33 D 11750 D Common Stock 2013-07-16 4 M 0 469 33.28 A 12219 D Common Stock 2013-07-16 4 S 0 469 85.75 D 11750 D Common Stock 169 I 401(k) Stock Option 33.82 2013-07-15 4 M 0 469 0.00 D 2020-07-13 Common Stock 469 1875 D Stock Option 51.75 2013-07-15 4 M 0 1125 0.00 D 2021-07-12 Common Stock 1125 9000 D Stock Option 33.28 2013-07-16 4 M 0 469 0.00 D 2019-07-15 Common Stock 469 0 D Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $86.34 (range $85.99 to $86.89). Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $85.75 (range $85.22 to $86.20). The option vests in 16 quarterly installments from 07/14/2010. The option vests in 16 quarterly installments from 07/13/2011. The option vests in 16 quarterly installments from 07/16/2009. Kenneth L. Horton, Attorney-In-Fact 2013-07-17